If you are considering whether to stay on or eventually discontinue, understanding potential semaglutide withdrawal symptoms helps you plan for either scenario
There is no clinical research specifically evaluating the safety of taking glycine with tirzepatide, so a definitive answer is not yet available
As Dave Moore, executive vice president, U.S
Saxenda was the first GLP-1 medication to get approval from the FDA for weight management in adults with obesity and overweight with at least one weight-related health condition as an adjunct to exercise, and lifestyle and dietary modifications
This means there will be a period of overlap where both medications are pharmacologically active
Each batch goes through strict third-party testing for purity, potency, and safety